title: Intraventricular insulin potentiates the anorexic effect of corticotropin releasing hormone in rats.
abstract: Intraventricular corticotropin releasing hormone (CRH) suppresses food intake and body weight as a stress response. Insulin, acting within the brain, also suppresses food intake and body weight, and this suppression is related to caloric homeostasis. We determined if increased insulin within the brain potentiates the anorexic effects of intraventricular CRH. Rats were food deprived for 17 h each day and then given 30-min access to Ensure. One-half received continuous third ventricular infusion of synthetic cerebrospinal fluid via osmotic minipumps, and one-half received insulin (0.6 mU/day). During the infusion, rats also received 0, 0.1, 1.0, or 5.0 microg of CRH into the lateral ventricle just before access to Ensure. Insulin alone had no effect on Ensure intake or body weight. CRH dose dependently reduced Ensure intake in both groups, and the reduction was greater in the insulin group. Hence, central insulin potentiated the ability of centrally administered CRH to suppress food intake. These findings suggest that stress-related influences over food intake, particularly those mediated via CRH, interact with relative adiposity as signaled to the brain by central insulin.
authors.affiliation: Veterans Affairs Puget Sound Health Care System, Seattle 98108, USA.
authors.forename: Ralph D
authors.initials: RD
authors.lastname: Richardson
authors.forename: Koichi
authors.initials: K
authors.lastname: Omachi
authors.forename: Rasoul
authors.initials: R
authors.lastname: Kermani
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Woods
mesh_terms: D000818:Animals; D001835:Body Weight / Q000187:drug effects*; D003346:Corticotropin-Releasing Hormone / Q000008:administration & dosage / Q000819:agonists* / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005247:Feeding Behavior / Q000187:drug effects*; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D007276:Injections, Intraventricular; D007328:Insulin / Q000008:administration & dosage* / Q000494:pharmacology*; D051381:Rats; D020318:Rats, Long-Evans; D013312:Stress, Physiological / Q000503:physiopathology
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D003346:Corticotropin-Releasing Hormone